Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2021-10-04 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Key Animal Study for EFS Submission Completed 2 pages 193.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 5 October 2021 from Anteris Technologies Ltd. It reports the completion of a key animal study related to the FDA early feasibility study submission for a clinical trial. The content focuses on preliminary study results and next steps for regulatory submission. The document is relatively short (3428 characters) and serves as a news update rather than a detailed financial or regulatory report. It does not contain financial statements, management discussion, or detailed regulatory filings. It is not a report publication announcement since it does not mention an attached report or provide a link to a report. The document is best classified as a general regulatory announcement about a clinical study milestone, fitting the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2021-10-04 English
Notification regarding unquoted securities - AVR 9 pages 33.4KB
Share Issue/Capital Change Classification · 95% confidence The document is a detailed notification about the issue of unquoted equity securities, specifically unlisted options, by Anteris Technologies Ltd. It includes specifics such as the number of securities issued, exercise price, expiry date, and the purpose of the issue. The document also references shareholder approval and compliance with ASX listing rules. This type of document is an announcement related to changes in the company's capital structure, specifically the issuance of new securities. It is not a full financial report, audit, or management discussion, nor is it a regulatory filing or a report publication announcement. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail support a high confidence in this classification.
2021-09-29 English
Notification regarding unquoted securities - AVR 9 pages 32.7KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted securities under an employee incentive scheme. It includes specifics such as security descriptions, issue dates, number of securities issued, and mentions key management personnel receiving securities. The document is an announcement of a securities issuance event rather than a full financial report or detailed analysis. It does not contain financial statements or management discussion but focuses on capital structure changes related to share options and securities issuance. Therefore, it fits the category of a Share Issue/Capital Change announcement.
2021-09-28 English
Results of Meeting 2 pages 188.3KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement dated 23 September 2021 reporting the results of an Extraordinary General Meeting (EGM). It details the voting outcomes on various resolutions put to shareholders, including ratification and approval of prior share issues and approval of future option issues. The document includes proxy vote counts and confirms that all resolutions were carried. There is no financial data or detailed report content, only the official voting results. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is 4094 characters, which is short and focused solely on voting results, not a full report or presentation.
2021-09-22 English
Application for quotation of securities - AVR 8 pages 29.8KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary shares. It includes specifics about the number of securities, issue dates, and classifications under ASX rules. There is no indication of financial results, management discussion, or regulatory certifications. The content is focused on the issuance and quotation of new shares resulting from exercised options, which aligns with announcements about share issues or capital changes rather than financial reports or other categories. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length (6514 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2021-09-15 English
Notification regarding unquoted securities - AVR 10 pages 35.4KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted options under an employee incentive scheme by Anteris Technologies Ltd. It includes specifics such as security descriptions, issue dates, exercise prices, and compliance with ASX listing rules. There is no financial performance data, earnings information, or management discussion. The document is an official announcement regarding the issuance of new securities, specifically unquoted equity securities (options). This fits the category of Share Issue/Capital Change (SHA), which covers announcements about new share issues or capital changes. The document length is sufficient and contains detailed issuance information, confirming it is not a mere report publication announcement or a regulatory filing fallback. Therefore, the classification is SHA with high confidence.
2021-09-14 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.